Iperionx Ltd. ADR (IPX) AI Stock Analysis

• Market Cap: $689.64M
• Dividend Yield: N/A
• Average Volume (3M): 77.06K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.12
• Revenue Growth: N/A
• EPS Growth: -15.85%
• Country: US
• Employees: 28
• Sector: Basic Materials
• Sector Strength: 63
• Industry: Industrial Materials
• EPS (TTM): -0.05
• Shares Outstanding: 31,916,101
• 10 Day Avg. Volume: 38,848
• 30 Day Avg. Volume: 77,055
• PEG Ratio: 225.04
• Price to Book (P/B): 5.88
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -9.89
• Enterprise Value/Market Cap: >-0.01
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $28.00
• Price Target Upside: 22.65% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 35 Underperform
• Price Target: ―

Iperionx Ltd. ADR faces significant financial challenges with no revenue and consistent net losses, raising doubts about its long-term viability. Technically, the stock is in a bearish trend, though there are some neutral indicators. The negative P/E ratio and absence of a dividend yield further weigh on the stock's valuation. These factors combine to suggest caution for potential investors.

Iperionx Ltd. ADR Business Overview & Revenue Model

Company Description

IperionX Limited engages in the exploration and development of mineral properties. It explores for epithermal and replacement style precious and base metal mineralization, as well as titanium, rare earth elements, silica sand, and zircon minerals. The company holds a 100% interest in the Milford project that includes 101 claims located in Utah, the United States. It also holds a 100% interest in Titan project covering an area of approximately 6,000 acres situated in Tennessee, the United States. The company was formerly known as Hyperion Metals Limited and changed its name to IperionX Limited in February 2022. IperionX Limited was incorporated in 2017 and is headquartered in Charlotte, North Carolina.

How the Company Makes Money

Iperionx Ltd. generates revenue by producing and selling titanium metal powders and related products to industrial clients. The company's revenue model is primarily based on the sale of these advanced materials, which are in demand due to their lightweight, durable, and corrosion-resistant properties. Key revenue streams include contracts and sales agreements with manufacturers in sectors such as aerospace and automotive, where titanium's high performance is critical. Additionally, Iperionx may engage in partnerships and collaborations with other companies to enhance their product offerings and expand their market reach. The company's earnings are also influenced by their ability to innovate and improve production processes, thereby reducing costs and increasing profitability.

Iperionx Ltd. ADR Financial Statement Overview

Summary

Iperionx Ltd. ADR faces significant operational challenges with no revenue generation and continued net losses, raising concerns about long-term viability. While the balance sheet shows low leverage, the reliance on external financing underscores the need for strategic shifts to achieve profitability and growth.

Income Statement

The company has reported no revenue over several years, indicating a lack of operational sales activity. This persistent absence of revenue and the negative net income suggest significant challenges in generating profits.

Balance Sheet

The company maintains a strong equity position with a low debt-to-equity ratio, implying minimal financial leverage. However, the lack of revenue generation and recurring net losses raise concerns about the sustainability of its financial structure.

Cash Flow

The company consistently reports negative operating cash flow and free cash flow, highlighting challenges in cash generation. Nonetheless, there is a positive trend in financing cash flow, suggesting reliance on external funding to sustain operations.

Breakdown
TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
0.00	0.00	0.00	0.00	0.00	0.00
	Gross Profit
0.00	―	-634.11K	-211.58K	―	―
	EBIT
―	-23.01M	-26.26M	-21.85M	―	―
	EBITDA
―	-22.49M	-25.62M	-29.39M	-13.30M	―
	Net Income Common Stockholders
―	-22.23M	-25.93M	-21.52M	―	―
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
77.13M	33.16M	17.93M	5.67M	1.70M	―
	Total Assets
115.83M	55.44M	34.26M	9.91M	3.72M	―
	Total Debt
4.19M	1.49M	1.47M	543.03K	475.65K	―
	Net Debt
-72.93M	-31.67M	-16.47M	-5.13M	-1.22M	―
	Total Liabilities
10.29M	4.10M	3.37M	2.49M	762.50K	―
	Stockholders Equity
105.54M	51.34M	30.89M	7.42M	1.76M	―
Cash Flow		Free Cash Flow
-2.83M	-26.68M	-18.57M	-14.06M	-3.62M	―
	Operating Cash Flow
―	-18.68M	-15.86M	-12.13M	-3.56M	―
	Investing Cash Flow
-5.61M	-6.53M	-5.71M	-3.07M	1.76M	―
	Financing Cash Flow
97.00M	46.59M	27.89M	19.39M	3.50M	―

Iperionx Ltd. ADR Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 22.83
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IPX, the sentiment is Positive. The current price of 22.83 is above the 20-day moving average (MA) of 21.63, above the 50-day MA of 19.55, and above the 200-day MA of 22.76, indicating a bullish trend. The MACD of 0.64 indicates Negative momentum. The RSI at 58.71 is Neutral, neither overbought nor oversold. The STOCH value of 74.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IPX.

Iperionx Ltd. ADR Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ASIX	70 Neutral	$656.37M	7.84	11.26%	2.66%	6.03%	5079.05%
VHI	64 Neutral	$445.36M	3.83	11.76%	2.15%	7.82%	19465.71%
MTUS	58 Neutral	$548.40M	30.62	-3.00%	―	-23.34%	-128.05%
MAGN	51 Neutral	$454.97M	―	-30.78%	―	-9.02%	36.86%
Sector *	50 Neutral	$1.98B	-1.07	-21.34%	3.71%	2.03%	-30.65%
TMC	42 Neutral	$1.66B	―	-667.42%	―	―	-3.49%
IPX	35 Underperform	$689.64M	―	-40.55%	―	―	-15.85%